Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Teva
Federal Trade Commission
Citi
McKinsey
Express Scripts
Cipla
AstraZeneca
Colorcon
Chubb

Generated: January 16, 2018

DrugPatentWatch Database Preview

BACITRACIN ZINC AND POLYMYXIN B SULFATE Drug Profile

« Back to Dashboard

Which patents cover Bacitracin Zinc And Polymyxin B Sulfate, and what generic alternatives are available?

Bacitracin Zinc And Polymyxin B Sulfate is a drug marketed by Akorn, Bausch And Lomb, and Perrigo Co Tennessee. and is included in three NDAs.

The generic ingredient in BACITRACIN ZINC AND POLYMYXIN B SULFATE is bacitracin zinc; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the bacitracin zinc; polymyxin b sulfate profile page.
Summary for BACITRACIN ZINC AND POLYMYXIN B SULFATE
Drug patent expirations by year for BACITRACIN ZINC AND POLYMYXIN B SULFATE
Pharmacology for BACITRACIN ZINC AND POLYMYXIN B SULFATE

US Patents and Regulatory Information for BACITRACIN ZINC AND POLYMYXIN B SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn BACITRACIN ZINC AND POLYMYXIN B SULFATE bacitracin zinc; polymyxin b sulfate OINTMENT;OPHTHALMIC 064028-001 Jan 30, 1995 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bausch And Lomb BACITRACIN ZINC AND POLYMYXIN B SULFATE bacitracin zinc; polymyxin b sulfate OINTMENT;OPHTHALMIC 064046-001 Jan 26, 1995 AT RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Perrigo Co Tennessee BACITRACIN ZINC AND POLYMYXIN B SULFATE bacitracin zinc; polymyxin b sulfate OINTMENT;OPHTHALMIC 065022-001 Feb 27, 2002 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Federal Trade Commission
Citi
AstraZeneca
Mallinckrodt
Queensland Health
Moodys
Accenture
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot